144 related articles for article (PubMed ID: 35579164)
21. Liquid biopsies to optimize therapeutic efficacy in unresponsive lung cancer patients.
Santarpia M; Funel N; Ali A; Giovannetti E
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):761-763. PubMed ID: 29933706
[No Abstract] [Full Text] [Related]
22. Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients.
Doval DC; Deshpande R; Dhabhar B; Babu KG; Prabhash K; Chopra R; Sripada PV; Deshmukh C; Suryavanshi M
Indian J Cancer; 2017 Dec; 54(Supplement):S25-S30. PubMed ID: 29292705
[TBL] [Abstract][Full Text] [Related]
23. Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC.
Zheng MM; Li YS; Jiang BY; Tu HY; Tang WF; Yang JJ; Zhang XC; Ye JY; Yan HH; Su J; Zhou Q; Zhong WZ; Yang XN; Guo WB; Chuai S; Zhang Z; Chen HJ; Wang Z; Liu C; Wu YL
J Thorac Oncol; 2019 May; 14(5):924-932. PubMed ID: 30659989
[TBL] [Abstract][Full Text] [Related]
24. Role of Cytomorphology in the Era of Liquid Biopsy.
Clery E; Pisapia P; Vigliar E; Malapelle U; Bellevicine C; Troncone G; Schmitt FC
Acta Cytol; 2019; 63(6):497-505. PubMed ID: 30943469
[TBL] [Abstract][Full Text] [Related]
25. [Application of liquid biopsy in clinical practice: the importance of a scientific network for effective use of the biomolecular markers in NSCLC patient..].
MInelli M; Buzzacchino F; Lugini A
Recenti Prog Med; 2020 Nov; 111(11):29e-31e. PubMed ID: 33205777
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib.
Oya Y; Yoshida T; Asada K; Oguri T; Inui N; Morikawa S; Ito K; Kimura T; Kunii E; Matsui T; Kubo A; Kato T; Abe T; Tsuda T; Hida T
BMC Cancer; 2021 Jan; 21(1):57. PubMed ID: 33435905
[TBL] [Abstract][Full Text] [Related]
27. Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer.
Kasahara N; Kenmotsu H; Serizawa M; Umehara R; Ono A; Hisamatsu Y; Wakuda K; Omori S; Nakashima K; Taira T; Naito T; Murakami H; Koh Y; Mori K; Endo M; Nakajima T; Yamada M; Kusuhara M; Takahashi T
Lung Cancer; 2017 Apr; 106():138-144. PubMed ID: 28285688
[TBL] [Abstract][Full Text] [Related]
28. Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies.
Chang L; Li J; Zhang R
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188729. PubMed ID: 35436521
[TBL] [Abstract][Full Text] [Related]
29. Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.
Mambetsariev I; Vora L; Yu KW; Salgia R
BMC Cancer; 2018 Mar; 18(1):314. PubMed ID: 29562902
[TBL] [Abstract][Full Text] [Related]
30. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
Song Z; Wang W; Li M; Liu J; Zhang Y
Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and economic value of biomarker testing for targetable mutations in non-small-cell lung cancer: a literature review.
Zheng Y; Vioix H; Liu FX; Singh B; Sharma S; Sharda D
Future Oncol; 2022 Feb; 18(4):505-518. PubMed ID: 34865516
[TBL] [Abstract][Full Text] [Related]
32. Liquid biopsy assay for lung carcinoma using centrifuged supernatants from fine-needle aspiration specimens.
Hannigan B; Ye W; Mehrotra M; Lam V; Bolivar A; Zalles S; Barkoh BA; Duose D; Hu PC; Broaddus R; Stewart J; Heymach J; Medeiros LJ; Wistuba I; Luthra R; Roy-Chowdhuri S
Ann Oncol; 2019 Jun; 30(6):963-969. PubMed ID: 30887015
[TBL] [Abstract][Full Text] [Related]
33. Is tissue still the issue in detecting molecular alterations in lung cancer?
Liam CK; Mallawathantri S; Fong KM
Respirology; 2020 Sep; 25(9):933-943. PubMed ID: 32335992
[TBL] [Abstract][Full Text] [Related]
34. Navigating into a stormy sea: liquid biopsy enters peri-operative management in early-stage non-small cell lung cancer.
Rolfo C; Russo A
Ann Oncol; 2024 Feb; 35(2):147-149. PubMed ID: 38331558
[No Abstract] [Full Text] [Related]
35. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
Shields MD; Chen K; Dutcher G; Patel I; Pellini B
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272
[TBL] [Abstract][Full Text] [Related]
36. Tumor-educated platelet as liquid biopsy in lung cancer patients.
Liu L; Lin F; Ma X; Chen Z; Yu J
Crit Rev Oncol Hematol; 2020 Feb; 146():102863. PubMed ID: 31935617
[TBL] [Abstract][Full Text] [Related]
37. Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer.
Malapelle U; Pisapia P; Addeo A; Arrieta O; Bellosillo B; Cardona AF; Cristofanilli M; De Miguel-Perez D; Denninghoff V; Durán I; Jantus-Lewintre E; Nuzzo PV; O'Byrne K; Pauwels P; Pickering EM; Raez LE; Russo A; Serrano MJ; Gandara DR; Troncone G; Rolfo C
Expert Rev Mol Diagn; 2021 Nov; 21(11):1165-1178. PubMed ID: 34570988
[TBL] [Abstract][Full Text] [Related]
38. Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.
Romero A; Serna-Blasco R; Calvo V; Provencio M
Curr Treat Options Oncol; 2021 Aug; 22(10):86. PubMed ID: 34424428
[TBL] [Abstract][Full Text] [Related]
39. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H
Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819
[TBL] [Abstract][Full Text] [Related]
40. Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study.
Minari R; Mazzaschi G; Bordi P; Gnetti L; Alberti G; Altimari A; Gruppioni E; Sperandi F; Parisi C; Guaitoli G; Bettelli S; Longo L; Bertolini F; Pagano M; Bonelli C; Tagliavini E; Nicoli D; Ubiali A; Zangrandi A; Trubini S; Proietto M; Fiorentino M; Tiseo M;
Clin Lung Cancer; 2020 Sep; 21(5):e464-e473. PubMed ID: 32276870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
